Placebo News and Research

RSS

Epidural analgesics have no effect on the duration of the second stage of labor, study reveals

A study, published in the journal Obstetrics & Gynecology, indicated that epidural analgesia had no impact on the duration of the second stage of labor, fetal position during birth, prevalence of episiotomy, normal vaginal delivery rate, or any other fetal well-being measures investigated by researchers.

11 Oct 2017

Novel midday bright light therapy decreases symptoms of depression in bipolar patients

Daily exposure to bright white light at midday significantly decreased symptoms of depression and increased functioning in people with bipolar disorder, a recent Northwestern Medicine study found.

11 Oct 2017

Epidural medication has no effect on duration of labor, study shows

Epidural analgesia – a mix of anesthetics and narcotics delivered by catheter placed close to the nerves of the spine – is the most effective method of labor pain relief. In widespread use since the 1970s, epidurals have long been thought to slow the second stage of labor – defined as beginning when the cervix is completely dilated and ending when the baby is delivered.

10 Oct 2017

UIC study receives $3 million federal grant to study effects of inflammation on PCOS

The University of Illinois at Chicago has received a $3 million federal grant to study the effects of inflammation on polycystic ovary syndrome, or PCOS.

10 Oct 2017

GW researchers receive NIH award to bring Zika vaccine trial to Brazil

The National Institute of Allergy and Infectious Disease of the National Institutes of Health awarded more than $2 million to a research team at the George Washington University School of Medicine and Health Sciences to facilitate a Zika vaccine trial in Brazil.

9 Oct 2017

Drug treatment reduces gout flares in clinical study

As reported in the journal Arthritis & Rheumatology, the drug febuxostat reduced gout flares in a double-blind, placebo-controlled study of 314 adults with early gout.

4 Oct 2017

Transcranial direct current stimulation leads to reduction in MS-related fatigue

People with multiple sclerosis (MS) who underwent a non-invasive form of electrical brain stimulation experienced significant reductions in fatigue, a common and often debilitating symptom of the disease, according to new research from the Multiple Sclerosis Comprehensive Care Center at NYU Langone Health.

3 Oct 2017

Statin use linked to reduced risk of S aureus bloodstream infection

Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S aureus) bloodstream infection outside of a hospital, according to a new study in Mayo Clinic Proceedings.

3 Oct 2017

FDA approves Verzenio for advanced metastatic breast cancer

The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

2 Oct 2017

Study identifies possibility of umbilical cord-derived stem cells in treating heart failure

A new study published in the American Heart Association Journal Circulation Research suggests that stem cells derived from umbilical cord show promise in treating heart failure.

28 Sep 2017

Caffeine may not relieve movement symptoms for people with Parkinson's

Contrary to previous research, caffeine may not relieve movement symptoms for people with Parkinson's disease, according to a study published in the September 27, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

28 Sep 2017

Study shows benefits of delayed-release stimulant in children with ADHD

A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.

27 Sep 2017

Prescription drug linked to marked slowing of stomach emptying and weight loss

Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology & Hepatology.

26 Sep 2017

Study: Antibody neutralizes dengue and Zika virus in mice

Brazil and other areas hardest hit by the Zika virus – which can cause babies to be born with abnormally small heads – are also home to dengue virus, which is spread by the same mosquito species.

25 Sep 2017

BMC researchers studying possibility of weight loss drugs to combat cocaine addiction

Boston Medical Center's psychiatry team is studying a drug called lorcaserin, which targets the brain's serotonin receptors and could help reduce cocaine cravings as well as dampen the rewards associated with taking cocaine.

21 Sep 2017

$Study compares effect of two osteoporosis medicines on fractures$

Study compares effect of two osteoporosis medicines on fractures

A new treatment for osteoporosis provides major improvements in bone density and more effective protection against fractures than the current standard treatment.

19 Sep 2017

Study examines effectiveness of placebo and antidepressants in children, adolescents

Although the clinical efficacy of antidepressants in children and adolescents is proven, it is frequently accompanied by side effects. In addition, the influence of the placebo effect on the efficacy of antidepressants is unclear.

15 Sep 2017

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.

14 Sep 2017

Probiotics may become new preventative or therapeutic strategy for IBD-related colon cancer

In an innovative approach to colorectal cancer (CRC) prevention and treatment, scientists are studying ways to replace missing metabolites in patients prone to gut inflammation and CRC.

14 Sep 2017

Study reveals marijuana's potential effects in individuals at high risk for psychotic disorder

Marijuana may bring on temporary paranoia and other psychosis-related effects in individuals at high risk of developing a psychotic disorder, finds a preliminary study from researchers at Columbia University Medical Center.

14 Sep 2017

Placebo News and Research

Epidural analgesics have no effect on the duration of the second stage of labor, study reveals

Novel midday bright light therapy decreases symptoms of depression in bipolar patients

Epidural medication has no effect on duration of labor, study shows

UIC study receives $3 million federal grant to study effects of inflammation on PCOS

GW researchers receive NIH award to bring Zika vaccine trial to Brazil

Drug treatment reduces gout flares in clinical study

Transcranial direct current stimulation leads to reduction in MS-related fatigue

Statin use linked to reduced risk of S aureus bloodstream infection

FDA approves Verzenio for advanced metastatic breast cancer

Study identifies possibility of umbilical cord-derived stem cells in treating heart failure

Caffeine may not relieve movement symptoms for people with Parkinson's

Study shows benefits of delayed-release stimulant in children with ADHD

Prescription drug linked to marked slowing of stomach emptying and weight loss

Study: Antibody neutralizes dengue and Zika virus in mice

BMC researchers studying possibility of weight loss drugs to combat cocaine addiction

Study compares effect of two osteoporosis medicines on fractures

Study examines effectiveness of placebo and antidepressants in children, adolescents

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Probiotics may become new preventative or therapeutic strategy for IBD-related colon cancer

Study reveals marijuana's potential effects in individuals at high risk for psychotic disorder

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News